当代心脏ICU中的高级呼吸支持
该前瞻性队列研究纳入2017至2019年北美25个心脏ICU连续两个月的8240例内科心脏ICU入院患者,评估有创机械通气、无创通气及经鼻高流量氧疗的使用情况及其与院内死亡率的关系。结果显示23.5%接受有创机械通气,7.0%接受无创通气,3.4%接受经鼻高流量氧疗;再插管率为7.6%。呼吸功能不全最常见相关因素为心力衰竭、感染、COPD和肺血管疾病。
要点
- 心脏ICU入院患者中23.5%接受有创机械通气,7.0%接受无创通气,3.4%接受经鼻高流量氧疗。
- 接受高级呼吸支持者的再插管率为7.6%。
- 呼吸功能不全最常见相关变量为心力衰竭、感染、COPD和肺血管疾病。
适用人群与场景
- 2017至2019年北美25个心脏ICU连续两个月收治的所有内科心脏ICU入院患者(共8240例)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为前瞻性队列研究,数据来自美国与加拿大心脏ICU组成的 Critical Care Cardiology Trials Network,共25个心脏ICU,纳入2017至2019年每年连续两个月全部内科心脏ICU入院,共8240例。
- 高级呼吸支持使用情况:有创机械通气1935例(23.5%),无创通气573例(7.0%),经鼻高流量氧疗281例(3.4%)。
- 接受高级呼吸支持者的入院诊断多样,包括心脏病患者的一般内科问题及原发性心脏问题。
- 再插管率为7.6%。
- 与呼吸功能不全相关的最常见变量包括心力衰竭、感染、COPD和肺血管疾病。
证据类型、等级与局限
- 证据类型为前瞻性队列研究。
- 局限:原文未明确列出研究局限;设计上为观察性研究,调整OR仅提示关联,不能推断因果。
对床旁实践的改变
- 原文指出约三分之一心脏ICU入院患者接受呼吸支持且与死亡率升高相关,该数据可为心脏ICU质量改进提供基准,并用于心脏重症培训与人员配置参考。
- 原文未提及具体的适用与不适用人群调整或常见陷阱。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The medical complexity and critical care needs of patients admitted to cardiac ICUs are increasing, and prospective studies examining the underlying cardiac and noncardiac diagnoses, the management strategies, and the prognosis of cardiac ICU patients with respiratory failure are needed.
DESIGN: Prospective cohort study.
SETTING: The Critical Care Cardiology Trials Network is a research collaborative of cardiac ICUs across the United States and Canada.
PATIENTS: We included all medical cardiac ICU admissions at 25 cardiac ICUs during two consecutive months annually at each center from 2017 to 2019.
MEASUREMENTS: We evaluated the use of advanced respiratory therapies including invasive mechanical ventilation, noninvasive ventilation, and high-flow nasal cannula versus no advanced respiratory support across admission diagnoses and the association with in-hospital mortality.
MAIN RESULTS: Of 8,240 cardiac ICU admissions, 1,935 (23.5%) were treated with invasive mechanical ventilation, 573 (7.0%) with noninvasive ventilation, and 281 (3.4%) with high-flow nasal cannula. Admitting diagnoses among those with advanced respiratory support were diverse including general medical problems in patients with heart disease as well as primary cardiac problems. In-hospital mortality was higher in patients who received invasive mechanical ventilation (38.1%; adjusted odds ratio, 2.53; 2.02-3.16) and noninvasive ventilation or high-flow nasal cannula (8.8%; adjusted odds ratio, 2.25; 1.73-2.93) compared with patients without advanced respiratory support (4.6%). Reintubation rate was 7.6%. The most common variables associated with respiratory insufficiency included heart failure, infection, chronic obstructive pulmonary disease, and pulmonary vascular disease.
CONCLUSIONS: One-third of cardiac ICU admissions receive respiratory support with associated increased mortality. These data provide benchmarks for quality improvement ventures in the cardiac ICU, inform cardiac critical care training and staffing patterns, and serve as foundation for future studies aimed at improving outcomes.
参考来源
- Metkus TS, Miller PE, Alviar CL, et al. Advanced Respiratory Support in the Contemporary Cardiac ICU. Crit Care Explor. 2020. PMID: 33235999. doi:10.1097/CCE.0000000000000182
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。